Prenatally engineered autologous amniotic fluid stem cell-based heart valves in the fetal circulation

Biomaterials

Volumn 33, Issue 16, 2012, Pages 4031-4043

  Weber, Benedikt ^a   Emmert, Maximilian Y ^a   Behr, Luc ^b   Schoenauer, Roman ^a   Brokopp, Chad ^a   Drögemüller, Cord ^c   Modregger, Peter ^d,e   Stampanoni, Marco ^d,f   Vats, Divya ^f   Rudin, Markus ^f   Bürzle, Wilfried ^f   Farine, Marc ^f   Mazza, Edoardo ^f,g   Frauenfelder, Thomas ^a   Zannettino, Andrew C ^h   Zünd, Gregor ^a   Kretschmar, Oliver ⁱ   Falk, Volkmar ^a   Hoerstrup, Simon P ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

^c UNIVERSITY OF BERN   (Switzerland)

^d PAUL SCHERRER INSTITUTE   (Switzerland)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

^f ETH ZURICH   (Switzerland)

^g SWISS FEDERAL LABORATORIES FOR MATERIALS SCIENCE AND TECHNOLOGY   (Switzerland)

^h UNIVERSITY OF ADELAIDE   (Australia)

ⁱ UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

Amniotic fluid stem cells; Composite matrix; Fetal model; Heart valve; Prenatal intervention; Tissue engineering

Indexed keywords

AMNIOTIC FLUID; CARDIAC INTERVENTIONS; CELL-BASED; COMPOSITE MATRICES; COMPOSITE MATRIX; FETAL CIRCULATION; GESTATIONAL AGE; HEART VALVE; HEART VALVES; HYBRID APPROACH; IN-VITRO; IN-VIVO; POSTNATAL DEVELOPMENT; PRENATAL INTERVENTION; SONOGRAPHIC; THROMBUS FORMATION; TISSUE-ENGINEERED HEART; VALVE REPLACEMENT;

ANIMALS; ECHOCARDIOGRAPHY; STEM CELLS; TISSUE; TISSUE ENGINEERING; ULTRASONOGRAPHY;

HEART;

4 HYDROXYBUTYRIC ACID; NANOCOMPOSITE; POLYGLYCOLIC ACID;

AMNIOTIC FLUID CELL; ANGIOGRAPHY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOLOGOUS AMNIOTIC FLUID STEM CELL BASED HEART VALVE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIODEGRADABLE IMPLANT; CELL ENGINEERING; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; FETUS; FETUS CIRCULATION; GESTATIONAL AGE; HEART VALVE PROSTHESIS; IN UTERO STEM CELL TRANSPLANTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRENATAL CARE; PRIORITY JOURNAL; SHEEP; STENT; SURVIVAL; THROMBOGENESIS; TISSUE ENGINEERING; TRICUSPID VALVE; ULTRASOUND;

AMNIOTIC FLUID; ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMECHANICS; FETAL BLOOD; HEART VALVES; SHEEP; STEM CELLS; TISSUE ENGINEERING; ULTRASONOGRAPHY, PRENATAL;

ANIMALIA; OVIS ARIES;

EID: 84858800611     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.11.087     Document Type: Article

References (42)

1. Schoen F.J. Evolving concepts of cardiac valve dynamics: the continuum of development, functional structure, pathobiology, and tissue engineering. Circulation 2008, 118:1864-1880.
2. Schmidt D., Mol A., Breymann C., Achermann J., Odermatt B., Goessi M., et al. Living autologous heart valves engineered from human prenatally harvested progenitors. Circulation 2006, 114:I125-I131.
3. Schmidt D., Achermann J., Odermatt B., Breymann C., Mol A., Genoni M., et al. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source. Circulation 2007, 116:I64-I70.
4. Schmidt D., Dijkman P.E., Driessen-Mol A., Stenger R., Mariani C., Puolakka A., et al. Minimally-invasive implantation of living tissue engineered heart valves: a comprehensive approach from autologous vascular cells to stem cells. J Am Coll Cardiol 2010, 56:510-520.
5. Dahl S.L., Kypson A.P., Lawson J.H., Blum J.L., Strader J.T., Li Y., et al. Readily available tissue-engineered vascular grafts. Sci Transl Med 2011, 68:68-69.
6. Weber B., Scherman J., Emmert M.Y., Gruenenfelder J., Verbeek R., Bracher M., et al. Injectable living marrow stromal cell-based autologous tissue engineered heart valves: first experiences with a one-step intervention in primates. Eur Heart 2011, 32:2830-2840.
7. Emmert M.Y., Weber B., Behr L., Frauenfelder T., Brokopp C., Grunenfelder J., et al. Aortic Implantation of marrow stromal cell-based tissue engineered heart valves - first experiences in the systemic circulation. JACC Cardiovasc Interv 2011, 4:822-823.
8. Mujezinovic F., Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007, 110:687-694.
9. Weber B., Zeisberger S.M., Hoerstrup S.P. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous iImplants prior to birth. Placenta 2011, 32:316-319.
10. Coolen N.A., Schouten K.C., Boekema B.K., Middelkoop E., Ulrich M.M. Wound healing in a fetal, adult, and scar tissue model: a comparative study. Wound Repair Regen 2010, 18:291-301.
11. Gurtner G.C., Werner S., Barrandon Y., Longaker M.T. Wound repair and regeneration. Nature 2008, 453:314-321.
12. Iwasaki H., Kawamoto A., Willwerth C., Horii M., Oyamada A., Akimaru H., et al. Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Arterioscler Thromb Vasc Biol 2009, 29:1830-1835.
13. McElhinney D.B., Tworetzky W., Lock J.E. Current status of fetal cardiac intervention. Circulation 2010, 121:1256-1263.
14. Kohl T., Szabo Z., Suda K., Petrossian E., Ko E., Kececioglu D., et al. Fetoscopic and open transumbilical fetal cardiac catheterization in sheep: potential approaches for human fetal cardiac intervention. Circulation 1997, 95:1048-1053.
15. Jouannic J.M., Boudjemline Y., Benifla J.L., Bonnet D. Transhepatic ultrasound-guided cardiac catheterization in the fetal lamb: a new approach for cardiac interventions in fetuses. Circulation 2005, 111:736-741.
16. Tulzer G., Arzt W., Franklin R.C., Loughna P.V., Mair R., Gardiner H.M. Fetal pulmonary valvuloplasty for critical pulmonary stenosis or atresia with intact septum. Lancet 2002, 360:1567-1568.
17. Tworetzky W., Wilkins-Haug L., Jennings R.W., van der Velde M.E., Marshall A.C., Marx G.R., et al. Balloon dilation of severe aortic stenosis in the fetus: potential for prevention of hypoplastic left heart syndrome: candidate selection, technique, and results of successful intervention. Circulation 2004, 110:2125-2131.
18. McElhinney D.B., Marshall A.C., Wilkins-Haug L.E., Brown D.W., Benson C.B., Silva V., et al. Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome. Circulation 2009, 120:1482-1490.
19. Kohl T., Tchatcheva K., Van de Vondel P., Gembruch U. Intraamniotic fetal echocardiography: a new fetal cardiovascular monitoring approach during human fetoscopic surgery. Circulation 2006, 114:594-596.
20. Galindo A., Gutiérrez-Larraya F., Velasco J.M., de la Fuente P. Pulmonary balloon valvuloplasty in a fetus with critical pulmonary stenosis/atresia with intact ventricular septum and heart failure. Fetal Diagn Ther 2006, 21:100-104.
21. Wilkins-Haug L.E., Tworetzky W., Benson C.B., Marshall A.C., Jennings R.W., Lock J.E. Factors affecting technical success of fetal aortic valve dilation. Ultrasound Obstet Gynecol 2006, 28:47-52.
22. Mol A., van Lieshout M.I., Dam-de Veen C.G., Neuenschwander S., Hoerstrup S.P., Baaijens F.P., et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. Biomaterials 2005, 26:3113-3121.
23. Hoffman J.I., Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002, 39:1890-1900.
24. Kohl T., Sharland G., Allan L.D., Gembruch U., Chaoui R., Lopes L.M., et al. World experience of percutaneous ultrasound-guided balloon valvuloplasty in human fetuses with severe aortic valve obstruction. Am J Cardiol 2000, 85:1230-1233.
25. Selamet Tierney E.S., Wald R.M., McElhinney D.B., Marshall A.C., Benson C.B., Colan S.D., et al. Changes in left heart hemodynamics after technically successful in-utero aortic valvuloplasty. Ultrasound Obstet Gynecol 2007, 30:715-720.
26. Weber B., Emmert M.Y., Behr L., Brokopp C., Frauenfelder T., Kretschmar O., et al. Fetal trans-apical stent delivery into the pulmonary artery: prospects for prenatal heart valve implantation. Eur J Cardiothor Surg 2011, 7.
27. De Coppi P., Bartsch G., Siddiqui M.M., Xu T., Santos C.C., Perin L., et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007, 25:100-106.
28. Shin'oka T., Imai Y., Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med 2001, 344:532-533.
29. Brennan M.P., Dardik A., Hibino N., Roh J.D., Nelson G.N., Papademitris X., et al. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg 2008, 248:370-377.
30. Roh J.D., Sawh-Martinez R., Brennan M.P., Jay S.M., Devine L., Rao D.A., et al. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A 2010, 107:4669-4728.
31. Mirensky T.L., Hibino N., Sawh-Martinez R.F., Yi T., Villalona G., Shinoka T., et al. Tissue-engineered vascular grafts: does cell seeding matter?. J Pediatr Surg 2010, 45:1299-1305.
32. Jux C., Bertram H., Wohlsein P., Brügmann M., Wüboldt P., Fink C., et al. Experimental ASD closure using autologous cell-seeded interventional closure devices. Cardiovasc Res 2002, 53:181-191.
33. Yoon B.S., Moon J.H., Jun E.K., Kim J., Maeng I., Kim J.S., et al. Secretory profiles and wound healing effects of human amniotic fluid-derived mesenchymal stem cells. Stem Cells Dev 2010, 19(6):887-902.
34. Perin L., Sedrakyan S., Giuliani S., Da Sacco S., Carraro G., Shiri L., et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 2010, 24:9357.
35. Teodelinda M., Michele C., Sebastiano C., Ranieri C., Chiara G. Amniotic liquid derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-arteriogenesis in an ischemic model. Biomaterials 2011, 32:3689-3699.
36. Mirebella T., Poggi A., Scaranari M., Mogni M., Lituania M., Baldo C., et al. Recruitment of host's progenitor cells to sites of human amniotic fluid stem cells implantation. Biomaterials 2011, 32:4218-4227.
37. Brandau S., Jakob M., Hemeda H., Bruderek K., Janeschik S., Bootz F., et al. Tissue-resident mesenchymal stem cells attract peripheral blood neutrophils and enhance their inflammatory activity in response to microbial challenge. J Leukoc Biol 2010, 88:1005-1015.
38. Sumanasinghe R.D., Pfeiler T.W., Monteiro-Riviere N.A., Loboa E.G. Expression of proinflammatory cytokines by human mesenchymal stem cells in response to cyclic tensile strain. J Cell Physiol 2009, 219:77-83.
39. Romieu-Mourez R., François M., Boivin M.N., Bouchentouf M., Spaner D.E., Galipeau J. Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype. J Immunol 2009, 182:7963-7973.
40. Shaw S.S., Bollini S., Abi Nader K., Gastadello A., Mehta V., Filppi E., et al. Autologous transplantation of amniotic fluid derived mesenchymal stem cells into sheep fetuses. Cell Transplant 2011, 20:1015-1031.
41. Klein J.D., Turner C.G., Steigman S.A., Ahmed A., Zurakowski D., Eriksson E., et al. Amniotic mesenchymal stem cells enhance normal fetal wound healing. Stem Cells Dev 2010, 20:969-976.
42. Ikai A., Riemer R.K., Ramamoorthy C., Malhotra S., Cassorla L., Amir G., et al. Preliminary results of fetal cardiac bypass in nonhuman primates. J Thorac Cardiovasc Surg 2005, 129:175-181.